Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
TDOC

TDOC - Teladoc Health Inc Stock Price, Fair Value and News

9.09USD-0.22 (-2.36%)Market Closed

Market Summary

TDOC
USD9.09-0.22
Market Closed
-2.36%

TDOC Stock Price

View Fullscreen

TDOC RSI Chart

TDOC Valuation

Market Cap

1.6B

Price/Earnings (Trailing)

-6.78

Price/Sales (Trailing)

0.6

EV/EBITDA

-9.73

Price/Free Cashflow

4.71

TDOC Price/Sales (Trailing)

TDOC Profitability

Operating Margin

95.09%

EBT Margin

-8.79%

Return on Equity

-10.18%

Return on Assets

-5.39%

Free Cashflow Yield

21.25%

TDOC Fundamentals

TDOC Revenue

Revenue (TTM)

2.6B

Rev. Growth (Yr)

2.68%

Rev. Growth (Qtr)

-2.18%

TDOC Earnings

Earnings (TTM)

-233.0M

Earnings Growth (Yr)

-18.29%

Earnings Growth (Qtr)

-183.45%

Breaking Down TDOC Revenue

Last 7 days

-0.6%

Last 30 days

-7.7%

Last 90 days

-28.3%

Trailing 12 Months

-63.1%

How does TDOC drawdown profile look like?

TDOC Financial Health

Current Ratio

3.82

Debt/Equity

0.67

Debt/Cashflow

0.22

TDOC Investor Care

Shares Dilution (1Y)

3.62%

Diluted EPS (TTM)

-1.41

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20242.6B000
20232.5B2.5B2.6B2.6B
20222.1B2.2B2.3B2.4B
20211.4B1.6B1.9B2.0B
2020605.5M716.3M867.1M1.1B
2019456.8M492.6M519.6M553.3M
2018280.0M330.0M372.3M417.9M
2017139.2M157.3M193.5M233.3M
201687.8M96.0M108.4M123.2M
201550.6M58.6M67.7M77.4M
2014027.8M35.7M43.5M
201300019.9M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Teladoc Health Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jul 02, 2024
nanis nikolaos p.
sold
-4,150
9.39
-442
chief technology officer
Jul 01, 2024
nanis nikolaos p.
acquired
-
-
1,233
chief technology officer
Jun 04, 2024
raman-tangella vidya
sold
-5,166
11.04
-468
chief medical officer
Jun 03, 2024
verstraete stephany
sold
-23,385
11.157
-2,096
chief marketing officer
Jun 03, 2024
geshuri arnnon
sold
-20,160
11.157
-1,807
chief people officer
Jun 03, 2024
raman-tangella vidya
sold
-12,518
11.157
-1,122
chief medical officer
Jun 03, 2024
kornwasser laizer
sold
-53,687
11.157
-4,812
president, enterprise growth
Jun 03, 2024
waters michael willem
sold
-47,372
11.157
-4,246
chief operating officer
Jun 03, 2024
turitz andrew
sold
-18,152
11.157
-1,627
evp, corporate development
Jun 03, 2024
cave james l.
sold
-9,528
11.157
-854
interim cao

1–10 of 50

Which funds bought or sold TDOC recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jul 18, 2024
Compagnie Lombard Odier SCmA
unchanged
-
-3,501
6,435
-%
Jul 18, 2024
Triad Wealth Partners, LLC
new
-
763
763
-%
Jul 18, 2024
Tradewinds Capital Management, LLC
unchanged
-
-80.00
147
-%
Jul 18, 2024
VALLEY NATIONAL ADVISERS INC
added
21.37
-1,000
4,000
-%
Jul 18, 2024
Gradient Investments LLC
new
-
166
166
-%
Jul 18, 2024
Center for Financial Planning, Inc.
unchanged
-
-266
489
-%
Jul 18, 2024
Blue Trust, Inc.
added
638
28,645
33,130
-%
Jul 17, 2024
Householder Group Estate & Retirement Specialist, LLC
reduced
-80.07
-16,332
2,000
-%
Jul 17, 2024
SteelPeak Wealth, LLC
added
181
155,627
344,785
0.02%
Jul 17, 2024
BROWN, LISLE/CUMMINGS, INC.
added
22.22
-1,416
5,379
-%

1–10 of 47

Are Funds Buying or Selling TDOC?

Are funds buying TDOC calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own TDOC
No. of Funds

Unveiling Teladoc Health Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Jul 08, 2024
blackrock inc.
12.8%
21,666,205
SC 13G/A
Feb 13, 2024
nikko asset management americas, inc.
4.50%
7,464,874
SC 13G/A
Feb 13, 2024
vanguard group inc
10.58%
17,514,904
SC 13G/A
Feb 05, 2024
sumitomo mitsui trust holdings, inc.
4.51%
7,474,674
SC 13G/A
Jan 29, 2024
ark investment management llc
12.82%
21,224,565
SC 13G/A
Jan 26, 2024
blackrock inc.
8.0%
13,203,121
SC 13G/A
Jul 10, 2023
vanguard group inc
10.58%
17,313,528
SC 13G/A
Feb 10, 2023
ark investment management llc
11.69%
18,928,440
SC 13G/A
Feb 10, 2023
nikko asset management americas, inc.
5.01%
8,125,231
SC 13G/A
Feb 09, 2023
vanguard group inc
8.94%
14,476,155
SC 13G/A

Recent SEC filings of Teladoc Health Inc

View All Filings
Date Filed Form Type Document
Jul 08, 2024
SC 13G/A
Major Ownership Report
Jul 05, 2024
8-K
Current Report
Jul 02, 2024
144
Notice of Insider Sale Intent
Jul 02, 2024
4
Insider Trading
Jun 18, 2024
S-8
Employee Benefits Plan
Jun 12, 2024
3
Insider Trading
Jun 12, 2024
4
Insider Trading
Jun 10, 2024
8-K
Current Report
Jun 04, 2024
4
Insider Trading
Jun 04, 2024
4
Insider Trading

Peers (Alternatives to Teladoc Health Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
520.4B
379.5B
17.33% 12.05%
33.88
1.37
12.96% -25.81%
95.4B
206.0B
1.72% 16.37%
24.76
0.46
12.55% -43.95%
84.3B
66.7B
-5.62% 12.14%
15.42
1.26
9.59% -4.59%
74.8B
360.9B
-1.82% -19.47%
10.21
0.21
9.07% 78.83%
35.4B
155.5B
-1.07% -4.10%
12.93
0.23
6.34% 84.42%
12.2B
14.7B
-4.81% 19.04%
14.88
0.83
7.99% 19.23%
12.1B
12.3B
-4.32% 29.88%
14.83
0.98
5.77% 58.74%
MID-CAP
8.2B
2.3B
1.82% -0.86%
28.98
3.58
5.96% 18.29%
6.0B
3.0B
-2.69% -11.33%
-534.77
2.02
10.92% -104.06%
2.8B
1.5B
17.05% 40.55%
44.28
1.9
19.34% 40.15%
2.2B
3.5B
6.32% -49.56%
15.06
0.62
-27.67% -62.40%
SMALL-CAP
1.9B
1.1B
0.03% 29.58%
29.63
1.79
11.45% 30.74%
1.5B
3.0B
16.04% 110.14%
-8.5
0.49
4.98% 4.88%
72.7M
-
21.59% -10.97%
-4.81
-
- -1.05%
20.6M
21.6M
-0.62% 19.10%
40.5
0.95
9.04% -57.88%

Teladoc Health Inc News

Latest updates
Defense World9 hours ago
Seeking Alpha01 Jul 202407:00 am

Teladoc Health Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-2.2%646,131,000660,527,000660,238,000652,406,000629,244,000637,709,000611,402,000592,379,000565,350,000554,235,000521,658,000503,139,000453,675,000383,321,000288,812,000241,030,000180,799,000156,489,000137,969,000130,276,000128,573,000
Gross Profit---------------------83,896,000
Costs and Expenses5.4%733,253,000695,608,000724,963,000724,051,000706,346,0004,453,262,000683,132,0003,688,931,0007,234,729,000595,664,000582,234,000582,087,000538,353,000841,827,000308,537,000248,209,000201,810,000172,077,000157,913,000152,299,000151,460,000
  S&GA Expenses1.7%54,364,00053,451,00052,309,00053,530,00054,490,00056,279,00054,634,00057,930,00058,329,00059,330,00062,602,00063,856,00064,793,00093,942,00023,483,00018,687,00017,940,00016,751,00016,120,00015,832,00016,212,000
  R&D Expenses-9.5%81,388,00089,938,00084,289,00087,309,00086,985,00082,931,00084,590,00078,696,00087,412,00072,867,00080,250,00080,759,00078,008,00092,697,00029,958,00023,029,00019,257,00016,246,00015,746,00016,665,00015,987,000
EBITDA Margin-4.5%-0.08-0.08-1.42-1.47-2.74-5.56-4.10-4.29-3.09-0.05-0.37-0.42---------
Interest Expenses2.0%5,649,0005,538,0005,646,0005,835,0005,263,00010,151,0006,149,0005,562,000-5,480,000142,634,000-18,895,000-20,473,000-22,125,000-21,100,500-16,970,000-13,262,000-8,618,000-7,581,000-7,700,000-7,211,000-6,521,000
Income Taxes-23.5%2,690,0003,515,000-2,484,000-952,000681,000-1,841,000-1,171,000-1,188,000388,000-49,734,5003,643,0003,200,00087,000,000-85,457,500-2,300,000-2,399,000-700,000-4,125,000-7,300,000100,000742,000
Earnings Before Taxes-212.1%-79,199,000-25,375,000-59,557,000-66,129,000-68,547,000-3,811,912,000-74,647,000-3,102,649,000-6,674,135,000-60,726,000-80,697,000-130,623,000-112,610,000-479,424,000-38,174,000-28,081,000-30,314,000-23,169,000-27,644,000-29,234,000-29,408,000
EBT Margin-4.2%-0.09-0.08-1.55-1.59-2.86-5.68-4.27-4.44-3.24-0.19-0.43-0.47---------
Net Income-183.5%-81,889,000-28,890,000-57,073,000-65,177,000-69,228,000-3,810,071,000-73,476,000-3,101,461,000-6,674,523,000-10,985,000-84,340,000-133,819,000-199,649,000-393,967,000-35,884,000-25,682,000-29,603,000-19,044,000-20,346,000-29,324,000-30,150,000
Net Income Margin-5.1%-0.09-0.08-1.55-1.59-2.86-5.68-4.24-4.42-3.22-0.21-0.44-0.47---------
Free Cashflow-94.0%7,771,000128,678,00099,808,00099,278,00010,793,00059,354,00059,191,00089,927,000-35,660,00080,285,00075,385,00049,927,000---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-1.6%4,3214,3924,3284,3164,3094,3458,1048,10311,09217,73517,65317,61117,58217,7553,4492,4191,6031,6031,5681,5651,552
  Current Assets-0.2%1,4861,4891,3871,3211,2871,3151,2881,2571,2081,2251,1571,1051,0321,0601,3101,403596588558533541
    Cash Equivalents-2.3%1,0981,1241,0319598899189008818368938247847207331,1871,309508514475440434
  Inventory9.3%32.0030.0036.0034.0046.0056.0059.0060.0071.0073.0057.0057.0058.0056.0012.00------
  Net PPE-7.7%30.0032.0033.0030.0030.0030.0027.0027.0028.0027.0027.0028.0028.0029.0020.0010.0010.0010.0010.0010.0010.00
  Goodwill0%1,0731,0731,0731,0731,0731,0734,8464,8587,90014,50414,47014,45514,45214,5811,691900734746738748734
  Current Liabilities-7.6%38942140338338140041137130733130227626033320112497.0090.0085.0070.0072.00
  Long Term Debt0.1%1,5401,5391,5381,5371,5361,5351,5341,5341,5331,2261,2111,2011,3531,380953948447440434427421
    LT Debt, Current--------------43.00-------
    LT Debt, Non Current0.1%1,5401,5391,5381,5371,5361,5351,5341,5341,5331,2261,2111,2011,3531,380953948447440434427421
Shareholder's Equity-1.6%2,2892,3262,2942,2952,2912,3086,0536,0859,14316,04615,98816,00115,82915,8842,2311,2951,0001,0149941,0031,002
  Retained Earnings-0.5%-15,310-15,228-15,199-15,142-15,077-15,008-11,198-11,124-8,023-1,421-1,410-1,326-1,192-992-598-562-537-507-488-468-438
  Additional Paid-In Capital0.3%17,63817,59217,53517,47617,41017,35917,30017,23917,17717,47317,39917,31517,01716,8582,8351,8801,5721,5391,5101,4831,457
Shares Outstanding1.6%169167166165163163162161161157156154---------
Float----4,145---5,334---26,317---14,937---4,607-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-93.1%8,920130,082105,601101,18213,15665,54963,02192,469-31,74783,20876,59152,217-18,026-114,93632,19535,550-6,32018,12213,4906,149-7,892
  Share Based Compensation-9.6%42,32546,82352,96455,72546,03850,75455,66251,00060,43661,61571,70182,97086,300414,38020,90821,92818,31518,45717,35417,36813,523
Cashflow From Investing2.7%-35,512-36,506-37,647-36,570-45,624-53,891-41,448-44,837-27,567-20,075-34,708-2,168-16,030-413,925-155,460-9,662-11,9289,54713,194-5,0647,336
Cashflow From Financing198.6%1,751-1,7755,0684,2083,3534,381634-1,3342,8166,62578411,36322,17570,436422773,22515,05310,0419,1535,19810,702
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

TDOC Income Statement

2024-03-31
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]  
Revenue$ 646,131$ 629,244
Expenses:  
Cost of revenue (exclusive of depreciation and amortization, which are shown separately below)194,538190,107
Operating expenses:  
Advertising and marketing183,329176,790
Sales54,36454,490
Technology and development81,38886,985
General and administrative111,697114,145
Acquisition, integration, and transformation costs3735,944
Restructuring costs9,6738,102
Amortization of intangible assets95,05766,860
Depreciation of property and equipment2,8342,923
Total expenses733,253706,346
Loss from operations(87,122)(77,102)
Interest income(13,942)(8,911)
Interest expense5,6495,263
Other expense (income), net370(4,907)
Loss before provision for income taxes(79,199)(68,547)
Provision for income taxes2,690681
Net loss(81,889)(69,228)
Other comprehensive loss, net of tax:  
Currency translation adjustment(1,639)1,779
Comprehensive loss$ (83,528)$ (67,449)
Net loss per share, basic (in dollars per share)$ (0.49)$ (0.42)
Net loss per share, diluted (in dollars per share)$ (0.49)$ (0.42)
Weighted-average shares used to compute basic net loss per share (in shares)167,730,746162,922,691
Weighted-average shares used to compute diluted net loss per share (in shares)167,730,746162,922,691

TDOC Balance Sheet

2024-03-31
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 1,097,935$ 1,123,675
Accounts receivable, net of allowance for doubtful accounts of $3,530 and $4,240 at March 31, 2024 and December 31, 2023, respectively214,293217,423
Inventories32,26829,513
Prepaid expenses and other current assets141,769118,437
Total current assets1,486,2651,489,048
Property and equipment, net29,55032,032
Goodwill1,073,1901,073,190
Intangible assets, net1,614,2381,677,781
Operating lease - right-of-use assets37,50640,060
Other assets80,00780,258
Total assets4,320,7564,392,369
Current liabilities:  
Accounts payable37,67443,637
Accrued expenses and other current liabilities199,418178,634
Accrued compensation50,523102,686
Deferred revenue-current101,22995,659
Total current liabilities388,844420,616
Other liabilities1,0231,080
Operating lease liabilities, net of current portion39,97142,837
Deferred revenue, net of current portion15,00213,623
Deferred taxes, net47,47249,452
Convertible senior notes, net1,539,5461,538,688
Commitments and contingencies (Note 14)
Stockholders’ equity:  
Common stock, $0.001 par value; 300,000,000 shares authorized; 169,314,029 shares and 166,658,253 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively169167
Additional paid-in capital17,637,90217,591,551
Accumulated deficit(15,310,544)(15,228,655)
Accumulated other comprehensive loss(38,629)(36,990)
Total stockholders’ equity2,288,8982,326,073
Total liabilities and stockholders’ equity$ 4,320,756$ 4,392,369
TDOC
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company operates through two segments, Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its that licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.
 CEO
 WEBSITEteladochealth.com
 INDUSTRYHealthcare Plans
 EMPLOYEES4816

Teladoc Health Inc Frequently Asked Questions


What is the ticker symbol for Teladoc Health Inc? What does TDOC stand for in stocks?

TDOC is the stock ticker symbol of Teladoc Health Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Teladoc Health Inc (TDOC)?

As of Thu Jul 18 2024, market cap of Teladoc Health Inc is 1.58 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TDOC stock?

You can check TDOC's fair value in chart for subscribers.

What is the fair value of TDOC stock?

You can check TDOC's fair value in chart for subscribers. The fair value of Teladoc Health Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Teladoc Health Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for TDOC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Teladoc Health Inc a good stock to buy?

The fair value guage provides a quick view whether TDOC is over valued or under valued. Whether Teladoc Health Inc is cheap or expensive depends on the assumptions which impact Teladoc Health Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TDOC.

What is Teladoc Health Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Jul 18 2024, TDOC's PE ratio (Price to Earnings) is -6.78 and Price to Sales (PS) ratio is 0.6. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TDOC PE ratio will change depending on the future growth rate expectations of investors.